Promoting the appropriate use of oral antibiotics: There is some very good news

Pediatrics

Volumn 111, Issue 3, 2003, Pages 668-670

  Bauchner, Howard ^a,b   Besser, Richard E ^c  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; DRUG USE; MEDICAL SOCIETY; MULTIDRUG RESISTANCE; NONHUMAN; NOTE; PEDIATRICIAN; PRESCRIPTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PREVALENCE; UNITED STATES;

EID: 0037341274     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.111.3.668     Document Type: Note

References (47)

1. Paradise JL, Rockette HE, Colborn K, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 1997;99:318-333
2. Barnett ED, Teele DW, Klein JO, Cabral HJ, Kharasch SJ. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Pediatrics. 1997;99:23-28
3. Berman S, Byrnes P, Bondy J, Smith PJ, Lezotte D. Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric Medicaid population. Pediatrics. 1997;100:585-592
4. Arditi M, Mason EO, Bradley JS, et al: Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998;102:1087-1097
5. Hardie W, Roberts NE, Reising SF, Christie CD. Complicated parapneumonic effusions in children caused by penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics. 1998;101:388-392
6. Andrade M, Hoberman A, Glustein J, Paradise JL, Wald ER. Acute otitis media in children with bronchiolitis. Pediatrics. 1998;101:617-619
7. Tan TQ, Mason EO, Barson WJ, et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics. 1998;102:1369-1375
8. Arvola T, Laiho K, Torkkeli S. Prophylactic lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999;104(5). Available at http//www.pediatrics.org/cgi/contents/full/104/5/e64
9. Watson RL, Dowell SF, Jayaraman M, Keyserling H, Kolczak M, Schwartz B. Antimicrobial use for pediatric upper respiratory infections: reported practice, and parent beliefs. Pediatrics. 1999;104:1251-1257
10. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and c-reactive protein as markers of bacterial infections. Pediatrics. 1999;104:447-453
11. Mangione-Smith R, McGlynn EA, Elliott MN, Krogstad P, Brook RH. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics. 1999;103:711-718
12. Toltzis P, Hoyen C, Spinner-Block S, Salvator AE, Rice LB. Factors that predict preexisting colonization with antibiotic-resistant Gram-negative bacilli in patients admitted to a pediatric intensive care unit. Pediatrics. 1999;103:719-723
13. Levine OS, Farley M, Harrison L, Lefkowitz L, McGeer A, Schwartz B. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics. 1999;103(3). Available at http://www.pediatrics.org/cig/contents/full/103/3/e28
14. Bauchner H, Pelton S, Klein JO. Parents, physicians, and antibiotic use. Pediatrics. 1999;103:395-398
15. Deeks SL, Palacio R, Ruvinsky R, et al. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. Pediatrics. 1999;103:409-413
16. Feder HM, Gerber M, Randolph MF, Stelmach PS, Kaplan EL. Oncedaily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics. 1999;103:47-51
17. Dusdieker LB, Murphy J, Milavetz G. How much antibiotic suspension is enough? Pediatrics. 2000;106(1). Available at http://www.pediatrics.org/cgi/contents/hill/106/1/e10
18. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362-366
19. American Academy of Pediatrics, Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics. 2000;106:367-376
20. Pichichero ME, Green JL, Francis AB, Marsocci SM, Murphy ML. Outcomes after judicious antibiotic use for respiratory tract infections seen in a private pediatric practice. Pediatrics. 2000;105:753-759
21. Lan AJ, Colford, JM Jr. The impact of dosing frequency on the efficacy of 10-day penicillin or amoxicillin therapy for streptococcal tonsillopharyngitis: a meta-analysis. Pediatrics. 2000;105(2). Available at: http://www.pediatrics.org/cgi/contents/full/105/2/e19
22. Bass JW, Person DA, Chan DS. Twice-daily oral penicillin for treatment of streptococcal pharyngitis: less is better. Pediatrics. 2000;105:423-425
23. Belongia EA, Sullivan BJ, Chyou P, Madagame E, Reed KD, Schwartz B. A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children. Pediatrics. 2001;108:575-583
24. Wheeler JG, Fair M, Simpson P, Rowlands LA, Aitken ME, Jacobs RF. Impact of a waiting room videotape message on parent attitudes towards pediatric antibiotic use. Pediatrics. 2001;108:591-596
25. Clinical practice guideline: management of sinusitis. Pediatrics. 2001;108:798-808
26. Toltzis P, Dul MJ, Hoyen C, et al. Molecular epidemiology of antibiotic-resistant Gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period. Pediatrics. 2001;108:1143-1148
27. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1-7
28. Trepka MJ, Belongia EA, Chyou P, Davis JP, Schwartz B. The effect of a community intervention trial on parental knowledge and awareness of antibiotic resistance and appropriate antibiotic use in children. Pediatrics. 2001;107(1). Available at: http://www.pediatrics.org/cgi/content/full/107/1/e6
29. Christakis DA, Zimmerman FJ, Wright JA, Garrison MM, Rivara FP, Davis RL. A randomized controlled trial of point-of-care evidence to improve the antibiotic prescribing practices for otitis media in children. Pediatrics. 2001;107(2). Available at: http://www.pediatrics.org/cgi/content/full/10T/2/e15
30. Garbutt JM, Goldstein M, Gellman E, Shannon W, Littenberg B. A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics. 2001;107:619-625
31. Bauchner H, Osganian S, Smith K, Triant R. Improving parent knowledge about antibiotics: a video intervention. Pediatrics. 2001;108:845-850
32. Samore M, Magill MK, Alder SC, et al. High rate of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics. 2001;108:856-865
33. Dowell SF, ed. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics. 2002;10:163-184
34. McCaig L, Besser R, Hughes J. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287:3096-3102
35. Finkelstein J, Stille C, Nordin J, et al. Decreasing antibiotic use in US children: 1995-2000. Pediatr Res 2002;51:213A
36. Kolagotla L, Bauchner H, Klein JO. Use of conjugate pneumococcal vaccine will alter management of fever and acute otitis media [abstract]. Pediatri Res. 2002;51:219A
37. Besser R. How to alter prescription patterns: promoting appropriate antibiotic use. In: Soulsby L, Wilbur R, eds. Antimicrobial Resistance: Proceedings of a Meeting Held in Washington, 4-5th May, 2000. London, U.K.: RSM Press; 2001:151-158
38. Hennessy TW, Petersen KM, Brudgen D, et al. Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska. Clin Infect Dis. 2002;34:1543-1550
39. Hamm R, Hicks R, Bemben D. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract. 1996;43:56-62
40. Barden LS, Dowell SF, Schwartz B, Lackey C. Current attitudes regarding use of antimicrobial agents: Results from physicians' and parents' focus group discussions. Clin Pediatr. 1998;37:665-672
41. Belongia E, Naimi T, Gale C, Besser R. Antibiotic use and upper respiratory infections: surveys of knowledge, attitudes and experience in Minnesota and Wisconsin. Prev Med. 2002;34:346-352
42. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-195
43. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:402-409
44. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of five attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med. 1998;338:1405-1412
45. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33:757-762
46. Whitney CG, Lynfield R, Hadler J, et al. Conjugate vaccine impact on antimicrobial resistance in the pneumococcus in the U.S.A. Presented at: Third International Symposium on Pneumococci and Pneumococcal Diseases; May 5-9, 2002; Anchorage, AK
47. Emmer C, Besser R. Combating antimicrobial resistance: intervention programs to promote appropriate antibiotic use. Infect Med. 2002;19:160-173